With the rise of computational modelling in the biotech industry, an emphasis is being put on the development of open-source toolkits for the simulation of drug-like molecular compounds in complex with proteins, fueling a rapid increase in computationally aided drug design. However, these workflows are often computationally expensive and are being migrated to the cloud. So what does cloud based drug discovery look like?
Read More ›